⌘K
Loading ticker…
As of 2026-08-21, Mustang Bio, Inc. (MBIO) has a 3-month relative strength percentile of 36 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 37. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.9%, relative volume 0.21×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MBIO is in a stage 4 downtrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -9.9% / -32.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
MBIO appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $19K notional.
Held by 1 ETFs · $19K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $19K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MBIO Jan avg: 6.36% median: 2.52% win: 50% σ: 50.43% n: 4 2022-04-12 → 2026-07-31 | MBIO Feb avg: -18.53% median: -12.54% win: 25% σ: 25.34% n: 4 2022-04-12 → 2026-07-31 | MBIO Mar avg: -30.43% median: -30.63% win: 0% σ: 6.34% n: 4 2022-04-12 → 2026-07-31 | MBIO Apr avg: -25.48% median: -17.32% win: 20% σ: 29.77% n: 5 2022-04-12 → 2026-07-31 | MBIO May avg: 5.82% median: -9.57% win: 40% σ: 29.31% n: 5 2022-04-12 → 2026-07-31 | MBIO Jun avg: 20.13% median: -2.82% win: 40% σ: 65.34% n: 5 2022-04-12 → 2026-07-31 | MBIO Jul avg: -1.01% median: -16.26% win: 20% σ: 35.70% n: 5 2022-04-12 → 2026-07-31 | MBIO Aug avg: -12.86% median: -8.57% win: 25% σ: 19.47% n: 4 2022-04-12 → 2026-07-31 (current) | MBIO Sep avg: -18.27% median: -19.53% win: 25% σ: 14.74% n: 4 2022-04-12 → 2026-07-31 | MBIO Oct avg: 2.25% median: 5.39% win: 50% σ: 18.53% n: 4 2022-04-12 → 2026-07-31 | MBIO Nov avg: -12.62% median: -9.48% win: 0% σ: 11.43% n: 4 2022-04-12 → 2026-07-31 | MBIO Dec avg: -17.44% median: -16.54% win: 0% σ: 10.81% n: 4 2022-04-12 → 2026-07-31 |